The Effects and Mechanisms of SLC34A2 in Tumorigenesis and Progression of Human Non-small Cell Lung Cancer

Overview

Journal J Biomed Sci

Publisher Biomed Central

Specialty Biology

Date 2015 Jul 10

PMID 26156586

Citations 26

Authors

Yu Wang

Weihan Yang

Qiang Pu

Yan Yang

Sujuan Ye

Qingping Ma

Jiang Ren

Zhixing Cao

Guoxing Zhong

Xuechao Zhang

Lunxu Liu

Wen Zhu

Affiliations

Soon will be listed here.

Abstract

Background: SLC34A2 with highest expressions in lung, small intestine and kidney encoded a type 2b sodium-dependent phosphate transporter (NaPi-IIb). In lung, SLC34A2 only expressed in the apical membrane of type II alveolar epithelium cells (ATII cells) and played a pivotal role during the fetal lung development and embryonic development. ATII cells acting as multifunctional stem cells might transform into NSCLC after undergoing exogenous or endogenous factors. Increasing evidences showed that the genes performing critical roles during embryogenesis were also expressed during the development of cancer. In addition, recent research found the expression of SLC34A2 had a significant difference between the surgical samples of NSCLC and normal tissues, and SLC34A2 was down-regulated in lung adenocarcinoma cell line A549 and up-regulation expression of SLC34A2 could significantly inhibit cell viability and invasion of A549 in vitro. These results suggested SLC34A2 might play an important role in the development of NSCLC. However, the role of SLC34A2 in tumorigenesis and progression of NSCLC remains unknown.

Results: Our study found that SLC34A2 was also significantly down-regulated in 14/15 of examined NSCLC tissues. Moreover, we found that expressions of SLC34A2 were reduced in six NSCLC cell lines for the first time. Our result also revealed a dramatic inhibitory effects of SLC34A2 on cell growth, migration and invasion of several NSCLC cell lines. SLC34A2 also strongly inhibited tumor growth and metastasis ability in A549 subcutaneous tumor model and lung metastasis model, respectively. Further studies found that the suppressive effects of SLC34A2 on tumorigenesis and progression might be associated with the down-regulation of related protein in PI3K/Akt and Ras/Raf/MEK signal pathway.

Conclusions: For the first time, our data indicated that SLC34A2 could exert significantly suppressive effects on tumorigenesis and progression of NSCLC. SLC34A2 might provide new insights for further understanding the early pathogenesis of human NSCLC.

Citing Articles

Proteogenomic characterization reveals tumorigenesis and progression of lung cancer manifested as subsolid nodules.

Su H, Chen L, Wu J, Cheng Z, Li J, Ren Y Nat Commun. 2025; 16(1):2414.

PMID: 40069142 PMC: 11897189. DOI: 10.1038/s41467-025-57364-x.

Porcine milk small extracellular vesicles modulate peripheral blood mononuclear cell proteome in vitro.

Avila G, Bonnet M, Viala D, Dejean S, Agazzi A, Lecchi C Sci Rep. 2025; 15(1):8069.

PMID: 40055486 PMC: 11889182. DOI: 10.1038/s41598-025-92550-3.

Fatty acid metabolism prognostic signature predicts tumor immune microenvironment and immunotherapy, and identifies tumorigenic role of MOGAT2 in lung adenocarcinoma.

Fu D, Zhang B, Fan W, Zeng F, Feng J, Wang X Front Immunol. 2024; 15:1456719.

PMID: 39478862 PMC: 11521851. DOI: 10.3389/fimmu.2024.1456719.

SLC34A2 Targets in Calcium/Phosphorus Homeostasis of Mammary Gland and Involvement in Development of Clinical Mastitis in Dairy Cows.

Wang X, Zhang B, Dong W, Zhao Y, Zhao X, Zhang Y Animals (Basel). 2024; 14(9).

PMID: 38731279 PMC: 11083581. DOI: 10.3390/ani14091275.

SLC34A2 promotes cell proliferation by activating STX17-mediated autophagy in esophageal squamous cell carcinoma.

Xu Y, Duan S, Ye W, Zheng Z, Zhang J, Gao Y Thorac Cancer. 2024; 15(17):1369-1384.

PMID: 38720472 PMC: 11168907. DOI: 10.1111/1759-7714.15314.

References

Hashimoto M, Wang D, Kamo T, Zhu Y, Tsujiuchi T, Konishi Y . Isolation and localization of type IIb Na/Pi cotransporter in the developing rat lung. Am J Pathol. 2000; 157(1):21-7. PMC: 1850224. DOI: 10.1016/S0002-9440(10)64512-9. View

Benfield J, van Krieken J, Dijkman J . The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas. Histol Histopathol. 1997; 12(2):319-36. View

Liu H, Kho A, Kohane I, Sun Y . Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development. PLoS Med. 2006; 3(7):e232. PMC: 1483910. DOI: 10.1371/journal.pmed.0030232. View

Gazdar A, Linnoila R, Kurita Y, Oie H, Mulshine J, Clark J . Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res. 1990; 50(17):5481-7. View

Traebert M, Hattenhauer O, Murer H, Kaissling B, Biber J . Expression of type II Na-P(i) cotransporter in alveolar type II cells. Am J Physiol. 1999; 277(5):L868-73. DOI: 10.1152/ajplung.1999.277.5.L868. View

Xu C, Jin H, Chung Y, Shin J, Hwang S, Kwon J . Low dietary inorganic phosphate affects the lung growth of developing mice. J Vet Sci. 2009; 10(2):105-13. PMC: 2801121. DOI: 10.4142/jvs.2009.10.2.105. View

Strizzi L, Bianco C, Normanno N, Salomon D . Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene. 2005; 24(37):5731-41. DOI: 10.1038/sj.onc.1208918. View

Zhang D, Brodt P . Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Oncogene. 2003; 22(7):974-82. DOI: 10.1038/sj.onc.1206197. View

Herbst R, Heymach J, Lippman S . Lung cancer. N Engl J Med. 2008; 359(13):1367-80. PMC: 10662965. DOI: 10.1056/NEJMra0802714. View

10.

Kinnard W, Tuder R, Papst P, Fisher J . Regulation of alveolar type II cell differentiation and proliferation in adult rat lung explants. Am J Respir Cell Mol Biol. 1994; 11(4):416-25. DOI: 10.1165/ajrcmb.11.4.7917310. View

11.

Jin H, Xu C, Lim H, Park S, Shin J, Chung Y . High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling. Am J Respir Crit Care Med. 2008; 179(1):59-68. PMC: 2615662. DOI: 10.1164/rccm.200802-306OC. View

12.

Monk M, Holding C . Human embryonic genes re-expressed in cancer cells. Oncogene. 2002; 20(56):8085-91. DOI: 10.1038/sj.onc.1205088. View

13.

Chang S, Yu K, Lee Y, An G, Beck Jr G, Colburn N . Elevated inorganic phosphate stimulates Akt-ERK1/2-Mnk1 signaling in human lung cells. Am J Respir Cell Mol Biol. 2006; 35(5):528-39. PMC: 2643273. DOI: 10.1165/rcmb.2005-0477OC. View

14.

Uhal B . Cell cycle kinetics in the alveolar epithelium. Am J Physiol. 1997; 272(6 Pt 1):L1031-45. DOI: 10.1152/ajplung.1997.272.6.L1031. View

15.

Kitinya J, Sueishi K, Tanaka K, Katsuda Y . Immunoreactivity of surfactant-apoprotein in adenocarcinomas, large cell and small cell carcinomas of the lung. Acta Pathol Jpn. 1986; 36(9):1271-8. DOI: 10.1111/j.1440-1827.1986.tb02848.x. View

16.

Feild J, Zhang L, Brun K, Brooks D, Edwards R . Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestine. Biochem Biophys Res Commun. 1999; 258(3):578-82. DOI: 10.1006/bbrc.1999.0666. View

17.

Corut A, Senyigit A, Ugur S, Altin S, Ozcelik U, Calisir H . Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet. 2006; 79(4):650-6. PMC: 1592565. DOI: 10.1086/508263. View

18.

Dreesen O, Brivanlou A . Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev. 2007; 3(1):7-17. DOI: 10.1007/s12015-007-0004-8. View

19.

Roberts P, Der C . Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007; 26(22):3291-310. DOI: 10.1038/sj.onc.1210422. View

20.

Williams T, Lisanti M . Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol. 2005; 288(3):C494-506. DOI: 10.1152/ajpcell.00458.2004. View